Grapiprant (Standard)
Grapiprant (Standard) is the analytical standard of Grapiprant. This product is intended for research and analytical applications. Grapiprant (CJ-023423) is a selective EP4 receptor antagonist whose physiological ligand is prostaglandin E2 (PGE2). Grapiprant displaces [3H]-PGE2 (1 nM) binding to dog recombinant EP4 receptor with IC50 value of 35 nM and Ki value of 24 nM. Grapiprant has the potential for osteoarthritic pain and inflammation treatment .
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 98%
- CAS. Nr.: 415903-37-6
- Formel: C26H29N5O3S
- Molecular Weight:491.61
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Reinheit & Dokumentation
-
Help & FAQs
-
HY-16781
GrapiprantEP4 Receptor Antagonist -
HY-B0131
Prostaglandin E1Vasodilator -
HY-16763
AsapiprantProstaglandin Receptor Antagonist -
HY-B0745
RamatrobanThromboxane A2 Receptor Antagonist -
HY-50901
ONO-AE3-208EP4 Recepto Antagonist -
HY-50175
LaropiprantDP Receptor Antagonist -
HY-18966
PF-04418948EP2 Receptor Antagonist -
HY-B0774
SeratrodastTXA2 Receptor Antagonist -
HY-B0191
BimatoprostProstaglandin Analog -
HY-10797
CJ-42794EP4 Antagonist -
HY-16963
GW627368Prostaglandin Receptor Antagonist -
HY-101987
BW 245CDP1 Agonist
Product Information
Information
Anwendung
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS. Nr. 415903-37-6
-
Molecular Weight 491.61
-
Formel C26H29N5O3S
-
SMILES
O=S(C1=CC=C(C)C=C1)(NC(NCCC2=CC=C(N3C(CC)=NC4=C3C=C(C)N=C4C)C=C2)=O)=O
-
Synonyms
CJ-023423 (Standard); RQ-00000007 (Standard); AAT-007 (Standard)
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Vito VD, et al. Detection and quantification of the selective EP4 receptor antagonist CJ-023423 (grapiprant) in canine plasma by HPLC with spectrofluorimetric detection. J Pharm Biomed Anal. 2016 Jan 25;118:251-8. [Content Brief]
[2]. Nagahisa A, et al. Pharmacology of grapiprant, a novel EP4 antagonist: receptor binding, efficacy in a rodent postoperative pain model, and a dose estimation for controlling pain in dogs. J Vet Pharmacol Ther. 2017 Jun;40(3):285-292. [Content Brief]
[3]. Rausch-Derra LC, et al. Evaluation of the safety of long-term, daily oral administration of grapiprant, a novel drug for treatment of osteoarthritic pain and inflammation, in healthy dogs.Am J Vet Res. 2015 Oct;76(10):853-9. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Grapiprant (Standard) Related Classifications
HY-16781R Related Classifications
Powered by Bioz